Chronic obstructive pulmonary disease (COPD) may originate in early life and share disease mechanisms with asthma-like symptoms in early childhood. This remains unexplored due to the lack of long-term prospective studies from infancy to the onset of COPD. We aimed to investigate the relationship between asthma-like symptoms in young children and development of COPD. In a population-based cohort of women giving birth at the central hospital in Copenhagen during 1959-1961 we investigated data from 3,290 mother-child pairs, who attended examinations during pregnancy and ages 1, 3 and 6 years. COPD was assessed from the Danish national registries on hospitalizations and prescription medication since 1994. A subgroup of 930 individuals underwent spirometry testing at age 50. One in four of the 3,290 children had a history of asthma-like symptoms in early childhood. The adjusted hazard ratio for hospitalization for COPD was 1.88 [95% CI, 1.32; 2.68] and the odds ratio for prescription of long-acting muscarinic antagonists was 2.27 [95% CI,1.38; 3.70]. Asthma-like symptoms in early childhood were also associated with reduced %predicted FEV1 and FEV1/FVC-ratio at age 50 (-3.36% [-5.47; -1.24] and -1.28 [-2.17; -0.38]), respectively, and with COPD defined according to GOLD stage>1, odds ratio 1.96 [1.13; 3.34]. This 60 year prospective follow-up of a mother-child cohort demonstrated a doubled risk for COPD from childhood asthma-like symptoms.
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Vitamin D insufficiency has become a common health problem worldwide, particularly among pregnant women and young children. Therefore, we sought to identify environmental, dietary, and genetic determinants of serum 25(OH)-vitamin D (25(OH)D) levels during pregnancy and early childhood. 25(OH)D was measured in women at 24-weeks of gestation (n = 738) and one-week postpartum (n = 284) in the population-based Danish COPSAC2010 mother–child cohort; and in cord blood (n = 257) and age 4 years (n = 298) in children from the at-risk COPSAC2000 mother–child cohort. Environmental, dietary, and genetic variables were tested for association with 25(OH)D using linear regression analyses. After adjusting for season of blood sampling, determinants of lower 25(OH)D levels during pregnancy in the women were higher pre-pregnancy BMI, lower age at birth, lower genetic vitamin D score, lower dietary vitamin D intake, and lower social circumstances. In children, the determinants were lower maternal age at birth, higher pre-pregnancy BMI, lower genetic vitamin D score, older siblings, exposure to tobacco smoking, and female sex. Genetics was an important determinant at all time points, alone explaining 2%–11% of the variance in 25(OH)D. Important determinants of circulating 25(OH)D levels during pregnancy and early childhood include environmental factors, diet, and to a large extent genetics.
Important questions remain regarding differences in geographical and age-specific mortality patterns as the COVID-19 pandemic evolved in consecutive waves, and how COVID-19 mortality compares to seasonal influenza. In a pandemic situation, excess all-cause mortality provides a more complete and robust measure than cause-specific mortality. Data submitted by 26 countries participating in the European Mortality Monitoring (EuroMOMO) network between 2020 and 2023 was analysed to quantify excess all-cause mortality during the COVID-19 pandemic. Excess mortality from this period was compared to previous influenza seasons from 2014 to 2019. Pooled estimates of excess mortality showed four main waves during the COVID-19 pandemic period, most markedly in people aged 65 years and above, with timing and magnitude that varied between countries. Here we show that prior to implementation of control measures and COVID-19 vaccination, excess mortality greatly exceeded typical seasonal influenza mortality, but later during the pandemic was at levels comparable to influenza.
Integration of unstructured and very diverse data is often required for a deeper understanding of complex biological systems. In order to uncover communalities between heterogeneous data, the data is often harmonized by constructing a kernel and numerical integration is performed. In this study we propose a method for data integration in the framework of an undirected graphical model, where the nodes represent individual data sources of varying nature in terms of complexity and underlying distribution, and where the edges represent the partial correlation between two blocks of data. We propose a modified GLASSO for estimation of the graph, with a combination of cross-validation and extended Bayes Information Criterion for sparsity tuning. Furthermore, hierarchical clustering on the weighted consensus kernels from a fixed network is used to partitioning the samples into different classes. Simulations show increasing ability to uncover true edges with increasing sample size and signal to noise . Likewise, identification of non existing edges towards disconnected nodes is feasible. The framework is demonstrated for integration of longitudinal symptom burden data from the 2nd and 3rd year of life with 21 diseases precursors as well as the development of asthma and eczema at the age of 6 years from 403 children from the COPSAC2010 mother-child cohort, suggesting that maternal predisposition as well as being born preterm indirectly lead to higher risk of asthma via increased respiratory symptom burden.